You have 9 free searches left this month | to do more

plerixafor

Plerixafor is a drug used to treat Multiple Myeloma, Non-Hodgkin's Lymphoma, Lymphoma, and other conditions. Plerixafor is being actively studied in 20 studies and prior, has been studied in 46.

Top SponsorsTop SitesTop Investigators
Genzyme, a Sanofi CompanyFred Hutch/University of Washington Cancer ConsortiumAlan K Burnett
Fred Hutchinson Cancer Research CenterWashington University School of MedicineAlessandra Biffi
Washington University School of MedicineWeill Cornell Medical CollegeCCTU- Cancer Theme
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Metastatic Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
2021-08-18
Aug 18, 2021
S
Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2021-11-28
Nov 28, 2021
S
Active, not recruiting
  • Multiple Myeloma
  • Stanford, California
    Stanford University
2021-08-16
Aug 16, 2021
A
Completed
  • Fanconi Anemia
  • Paris, France
    Hôpital necker-Enfants malades
2021-04-13
Apr 13, 2021
N
Completed
  • Myelokathexis
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-03-11
Mar 11, 2021
C
Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • Duarte, California
    City of Hope Medical Center
2021-02-10
Feb 10, 2021
L
Recruiting
  • Glioblastoma
  • +4 more
  • Plerixafor
  • +3 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
2021-05-03
May 3, 2021
M
Completed
  • Stem Cell Transplantation
  • Leukemia
  • Plerixafor
  • +5 more
  • Houston, Texas
    UT MD Anderson Cancer Center
2020-09-22
Sep 22, 2020
E
Recruiting
  • Transplants and Implants
  • plerixafor
  • +2 more
  • Cincinnati, Ohio
  • +1 more
2020-06-29
Jun 29, 2020
D
Completed
  • Multiple Myeloma
  • Plerixafor
  • +2 more
  • Boston, Massachusetts
  • +4 more
2020-05-19
May 19, 2020
G
Terminated
  • Diabetes
  • +2 more
  • Plerixafor
  • Placebo
  • Padova, Italy
    University Hospital of Padova
2019-12-17
Dec 17, 2019
F
Active, not recruiting
  • Multiple Myeloma
  • Plerixafor
  • Torino, Italy
    A.O.U. Città della Salute e della Scienza di Torino
2021-08-17
Aug 17, 2021
N
Completed
  • Sickle Cell Disease
  • Plerixafor
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2020-04-13
Apr 13, 2020
C
Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Plerixafor
  • Tampa, Florida
  • +11 more
2020-09-03
Sep 3, 2020
U
Recruiting
  • Diabetes Mellitus, Type 1
  • Plerixafor
  • +4 more
  • Edmonton, Alberta, Canada
    University of Alberta
2021-04-29
Apr 29, 2021
N
Recruiting
  • Idiopathic CD4 Positive
  • T-Lymphocytopenia
  • Filgrastim
  • Plerixafor
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-11-11
Nov 11, 2021
M
Terminated
  • Acute Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2019-08-19
Aug 19, 2019
F
Recruiting
  • Chronic Granulomatous Disease
  • Moscow, Russian Federation
    Dmitry Rogachev National Research Center of Pediatric Hematology
2019-09-16
Sep 16, 2019
U
Active, not recruiting
  • Myeloma
  • Chicago, Illinois
    University of Chicago
2021-09-14
Sep 14, 2021
U
Withdrawn
  • Bone Marrow Transplantation
  • +3 more
  • Baltimore, Maryland
    University of Maryland Medical Center
2019-12-09
Dec 9, 2019
M
Completed
  • Blood And Marrow Transplantation
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2019-04-01
Apr 1, 2019